Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 369 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bone Mass Clear all

Conditions: Breast Cancer
Interventions: Zoledronate; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older · Female only
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2008
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Patient Adherence
Interventions: Vitamin D Supplement; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older · Male only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 3
States / cities: Los Angeles, California • San Diego, California • Torrance, California

Conditions: Hip Arthroplasty
Interventions: Not listed
Lead sponsor: University of Nebraska; Other
Eligibility: Not listed
Enrollment: 203 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Postmenopausal Osteoporosis
Interventions: abaloparatide-sMTS; Combination Product
Lead sponsor: Radius Health, Inc.; Industry
Eligibility: 50 Years to 85 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Lenexa, Kansas

Conditions: Hypogonadism, Diabetes, Sarcopenia, Osteoporosis, Depression
Interventions: Androgel (Testosterone Gel), Anastrozole (Aromatase Inhibitor), Placebo tablet, Placebo gel, Calcium Cardone 500mg with vitamin D 400 IU; Drug · Dietary Supplement
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 65 Years and older · Male only
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Marfan Syndrome, Turner Syndrome, Ehlers-Danlos Syndrome, Loeys-Dietz Syndrome, FBN1, TGFBR1, TGFBR2, ACTA2 or MYH11 Genetic Mutation, Bicuspid Aortic Valve Without Known Family History, Bicuspid Aortic Valve With Family History, Bicuspid Aortic Valve With Coarctation, Familial Thoracic Aortic Aneurysm and Dissections, Shprintzen-Goldberg Syndrome, Other Aneur/Diss of Thoracic Aorta Not Due to Trauma, <50yo, Other Congenital Heart Disease
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 3,706 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2016
U.S. locations: 7
States / cities: Honolulu, Hawaii • Baltimore, Maryland • New York, New York + 3 more

Conditions: Joint Disease
Interventions: total hip arthroplasty implant; Device
Lead sponsor: MicroPort Orthopedics Inc.; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Lactation
Interventions: Not listed
Lead sponsor: University of Virginia; Other
Eligibility: 20 Years and older · Female only
Enrollment: 141 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2010
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Osteogenesis Imperfecta
Interventions: Pamidronate (Aredia); Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: Up to 16 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Bone Loss, Bone Density, Gastric Bypass, Bariatric Surgery
Interventions: Not listed
Lead sponsor: Gundersen Lutheran Medical Foundation; Other
Eligibility: 30 Years to 65 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: La Crosse, Wisconsin

Conditions: Osteoporosis, Bone Diseases, Metabolic
Interventions: Bone Mineral Density Result Letter and Bone Health Brochure; Behavioral
Lead sponsor: Fredric D Wolinsky; Other
Eligibility: 50 Years and older
Enrollment: 7,749 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 3
States / cities: Birmingham, Alabama • Atlanta, Georgia • Iowa City, Iowa

Conditions: Muscle Wasting (Atrophy) After Hip Fracture Surgery
Interventions: bimagrumab, placebo; Drug · Other
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 60 Years and older
Enrollment: 251 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 6
States / cities: Phoenix, Arizona • El Cajon, California • Denver, Colorado + 3 more

Conditions: Weight Loss, Bone Density, Obesity and Overweight
Interventions: Peanut Snack Experimental, Nut-free Snack; Dietary Supplement
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 50 Years to 75 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Renal Insufficiency
Interventions: Zoledronic Acid, Calcium with vitamin D, Alendronate; Drug · Combination Product
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2014
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Bone Mineral Density, Vascular Malformations
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 5 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Spinal Muscular Atrophy Type 3, Ambulatory Spinal Muscular Atrophy
Interventions: Not listed
Lead sponsor: Jacqueline Montes; Other
Eligibility: 8 Years to 50 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: End Stage Renal Disease, Kidney Transplantation, Bone Loss, Fractures, Vascular Calcifications
Interventions: Vitamin D3, Calcitriol, Placebo; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: HIV Infections
Interventions: Subjects do not receive study medication in this study 202094; Drug
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 7
States / cities: Los Angeles, California • San Francisco, California • Washington D.C., District of Columbia + 4 more

Conditions: Spinal Cord Injury
Interventions: Exoskeleton-Assisted Walking (EAW), Sham Transcutaneous Spinal Cord Stimulation (tSCS), Active Transcutaneous Spinal Cord Stimulation (tSCS); Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years to 60 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 2
States / cities: West Orange, New Jersey • The Bronx, New York

Conditions: Osteopenia
Interventions: Spry Belt; Device
Lead sponsor: Theranova, L.L.C.; Industry
Eligibility: 50 Years and older · Female only
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Osteopenia, Low Bone Density
Interventions: Spry Belt, Sham Spry Belt; Device
Lead sponsor: Bone Health Technologies, Inc.; Industry
Eligibility: 50 Years and older · Female only
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: San Francisco, California • Omaha, Nebraska

Conditions: Atrial Fibrillation
Interventions: Not listed
Lead sponsor: UConn Health; Other
Eligibility: 50 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Osteoporosis
Interventions: Psychoeducational program; Behavioral
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 9 Years to 13 Years · Female only
Enrollment: 340 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2002
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Osteoarthritis, Hip
Interventions: OMNI Apex Modular™ Hip Device, OMNI Apex ARC™ Hip Device; Device
Lead sponsor: Spokane Joint Replacement Center; Other
Eligibility: 20 Years to 80 Years
Enrollment: 73 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2018
U.S. locations: 1
States / cities: Spokane, Washington

Search by objective public record fields.

Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer

Effect of Vitamin D Supplementation on Bone Turnover Markers During PrEP in MSM

Stem Cells Predicting Orthopedic Outcomes

Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)

Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.

National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions

Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis

Bone Accrual and Hormones in Response to Lactation

Pamidronate to Treat Osteogenesis Imperfecta in Children

Bone Loss After Laparoscopic Roux-en-Y Gastric Bypass

Patient Activation After DXA Result Notification

Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery

Metabolic Health, Bones and Nuts During Weight Loss in Adults

Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants

Bone Health in Patients With Overgrowth

Gait and Bone Health in SMA

Bone Mass and Strength After Kidney Transplantation

Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen

Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation: Effect on Imaging and Serum Biomarkers of Skeletal Muscle Mass and Bone Strength.

Evaluation of the Spry Belt for Improving Bone Quality

Evaluation of the Effect of Spry Belt Treatment on Bone Turnover Marker Profile

Effect of Pradaxa vs Warfarin on Bone Mass and Bone Turnover Markers

Osteoporosis Prevention in Preadolescent Girls

Femoral Remodeling Following Total Hip Arthroplasty With OMNI Apex Modular™ and OMNI Apex ARC™ Stem Compared to Competitive Designs